• Dehydroabietic Acid: Dual PPAR-α/γ Agonist for Metabolic Ass

  2026-05-04

  Dehydroabietic acid empowers metabolic disorder research with robust, dual PPAR-α/γ activation and proven solubility for reproducible protocols. APExBIO’s high-purity reagent streamlines advanced workflows in lipid metabolism and insulin sensitivity modulation, supported by rigorous QC and innovative reference-backed applications.

• AngII Drives M1 Macrophage Polarization via Cx43/NF-κB Pathw

  2026-05-04

  This study demonstrates that Angiotensin II promotes M1-type polarization in RAW264.7 macrophages through upregulation of connexin 43 and activation of the NF-κB pathway. The findings clarify the mechanistic link between Cx43 hemichannels and pro-inflammatory macrophage responses, offering insights for targeted modulation in inflammation and atherosclerosis research.

• Optimizing Kidney-Targeted mRNA Nanoparticle Loading via Exc

  2026-05-03

  This study systematically investigates how different excipients impact the mRNA loading capacity, stability, and delivery efficiency of polymeric mesoscale nanoparticles for kidney-targeted applications. The findings offer practical strategies for enhancing reporter gene mRNA delivery, with implications for both therapeutic and molecular imaging workflows.

• Patient-Derived 3D Spheroids: A Versatile Model for Prostate

  2026-05-02

  This study establishes and characterizes patient-derived 3D spheroid cultures from radical prostatectomy tissues, providing a robust in vitro model of organ-confined prostate cancer. The model demonstrates functional androgen receptor signaling and drug response, offering new translational opportunities for prostate cancer research and preclinical drug evaluation.

• Nile Red: Precision Intracellular Lipid Droplet Staining

  2026-05-02

  Nile Red (Nile blue oxazone) is a gold-standard fluorescent probe for high-sensitivity intracellular lipid droplet staining, offering unparalleled flexibility through its dual-emission properties. This article explores optimized workflows, advanced experimental applications, and evidence-driven troubleshooting strategies to maximize data quality in lipid metabolism research.

• 3X (DYKDDDDK) Peptide: Optimizing FLAG-Tag Workflows in Prot

  2026-05-01

  The 3X (DYKDDDDK) Peptide streamlines affinity purification and immunodetection of recombinant proteins, offering enhanced sensitivity and workflow robustness. Explore practical protocols, troubleshooting strategies, and cutting-edge applications that leverage this trimeric epitope tag for reproducible, high-yield results.

• Nocodazole: Microtubule Polymerization Inhibitor in Cell Cyc

  2026-04-30

  Nocodazole stands as the benchmark microtubule polymerization inhibitor for dissecting cell cycle transitions, enabling precise control of mitotic arrest and downstream pathway interrogation. This article translates cutting-edge kinase-substrate insights into actionable protocols, workflow optimization, and troubleshooting strategies for robust microtubule dynamics research and anticancer drug evaluation.

• Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Regulatio

  2026-04-30

  This study identifies ATG9A and PTOV1 as previously unrecognized 14-3-3 binding proteins, elucidating their mechanistic roles in autophagy and oncogenic stability. The findings provide new insights into regulated protein interactions underlying tumor progression and highlight potential targets for conditional gene therapy strategies.

• Indazole/Indole Glucagon Receptor Antagonists: Synthesis and

  2026-04-29

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists, designed through systematic modification of the core scaffold to optimize antidiabetic activity. The work details innovative synthetic strategies, structure–activity relationship findings, and demonstrates promising in vitro and in vivo efficacy, guiding further development of small-molecule therapies for type 2 diabetes mellitus.

• AICAR: Precision AMPK Activation for Metabolic Disease Resea

  2026-04-29

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) from APExBIO empowers researchers to dissect energy metabolism and inflammation inhibition with robust, reproducible AMPK activation. This guide details proven workflows, advanced use-cases, and expert troubleshooting to accelerate metabolic disease and cellular stress research.

• 5-Methyl-CTP: Precision mRNA Engineering for Advanced Vaccin

  2026-04-28

  Unlock how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, empowers next-generation mRNA vaccine design by enhancing stability and translation. This article uniquely analyzes the impact of OMV-based delivery platforms and protocol decision-making for researchers.

• Strategic mRNA Synthesis: Mechanisms Driving Translational I

  2026-04-28

  This thought-leadership article explores how the HyperScribe™ All in One mRNA Synthesis Kit Plus 1 advances translational research by addressing immunogenicity, yield, and workflow integration for ARCA-capped, polyadenylated, and immune-evasive mRNA synthesis. Integrating mechanistic insights and lessons from cutting-edge neoantigen vaccine studies, it offers strategic guidance on protocol optimization, experimental design, and future directions for researchers developing RNA therapeutics and cell-based models.

• SLC11A1 Activates TGF-β1 to Resist Ferroptosis in Colorectal

  2026-04-27

  This study identifies SLC11A1 as a key driver of TGF-β1 pathway activation, conferring resistance to ferroptosis and promoting malignancy in colorectal cancer cells. These findings provide mechanistic insight into tumor progression and suggest potential molecular targets for future CRC therapies.

• Pemetrexed (SKU A4390): Data-Backed Solutions for Tumor Cell

  2026-04-27

  This article presents scenario-driven guidance for biomedical researchers using Pemetrexed (SKU A4390) in cell viability and cytotoxicity assays. Leveraging validated literature and practical workflow recommendations, it details best practices for assay optimization, data interpretation, and vendor selection—anchored by the reproducibility and performance of APExBIO's Pemetrexed.

• JC-1 Fluorescent Probe: Quantitative Strategies for Mitochon

  2026-04-26

  Explore advanced, quantitative approaches using JC-1 for mitochondrial membrane potential assays. This article delivers unique, evidence-based protocol guidance and decision-making frameworks for optimizing apoptosis detection and cellular bioenergetics studies.

461 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page